BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14740474)

  • 1. COX-2 inhibitor improves pain outcomes.
    OR Manager; 2004 Jan; 20(1):21. PubMed ID: 14740474
    [No Abstract]   [Full Text] [Related]  

  • 2. COX-2 inhibitors reduce knee replacement surgery problems.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Dec; 14(24):1, 5-6. PubMed ID: 14677563
    [No Abstract]   [Full Text] [Related]  

  • 3. [Selective COX-2 inhibitors--strong medicine for pain].
    MMW Fortschr Med; 2004 Apr; 146(17):56-7. PubMed ID: 15224910
    [No Abstract]   [Full Text] [Related]  

  • 4. The safety of the perioperative administration of cyclooxygenase-2 inhibitors for post-surgical pain.
    Reuben SS
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):424; author reply 425. PubMed ID: 15752415
    [No Abstract]   [Full Text] [Related]  

  • 5. [General practice study of therapy of acute pain. Patients prefer cox-2 inhibitors].
    MMW Fortschr Med; 2004 May; 146(21):61. PubMed ID: 15373091
    [No Abstract]   [Full Text] [Related]  

  • 6. [Minor rate of side-effects makes it possible. Coxibs accrue new indications].
    MMW Fortschr Med; 2004 Aug; 146(31-32):49. PubMed ID: 15529715
    [No Abstract]   [Full Text] [Related]  

  • 7. COX-2 inhibitors and hypercoagulability.
    Farkouh ME
    Clin Adv Hematol Oncol; 2005 Jan; 3(1):35-6. PubMed ID: 16166966
    [No Abstract]   [Full Text] [Related]  

  • 8. [The rise and fall of Vioxx: society, values and their choice].
    Caspi D
    Harefuah; 2004 Nov; 143(11):770-1. PubMed ID: 15603261
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis.
    Cobellis L; Razzi S; De Simone S; Sartini A; Fava A; Danero S; Gioffrè W; Mazzini M; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):100-2. PubMed ID: 15294376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does perioperative administration of rofecoxib improve analgesia after spine, breast and orthopaedic surgery?
    Riest G; Peters J; Weiss M; Pospiech J; Hoffmann O; Neuhäuser M; Beiderlinden M; Eikermann M
    Eur J Anaesthesiol; 2006 Mar; 23(3):219-26. PubMed ID: 16430794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [VIOXX written off--and what next? COX-2 inhibitors and cardiovascular diseases].
    Jerie P
    Cas Lek Cesk; 2005; 144(1):4. PubMed ID: 15789774
    [No Abstract]   [Full Text] [Related]  

  • 12. National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation.
    Dai C; Stafford RS; Alexander GC
    Arch Intern Med; 2005 Jan; 165(2):171-7. PubMed ID: 15668363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What happened to the coxibs on the way to the cardiologist?
    Alberts DS; Potter JD; Martinez ME; Hess LM; Stopeck A; Lance P
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):555-6. PubMed ID: 15767326
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cyclooxygenase-2 inhibitors in postoperative pain management].
    Güneş Y; Işik G
    Agri; 2004 Jul; 16(3):7-16. PubMed ID: 15382000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on efficacy of rofecoxib and nimesulide in controlling post-extraction pain in oral surgery: a randomised comparative study.
    Villa G
    Curr Med Res Opin; 2004 Apr; 20(4):573-4; author reply 574. PubMed ID: 15119995
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is there a future for COX-2 inhibitors?].
    Yodfat Y
    Harefuah; 2004 Nov; 143(11):820-4, 837. PubMed ID: 15603272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors.
    Couzin J
    Science; 2004 Oct; 306(5695):384-5. PubMed ID: 15486258
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of unresectable inflammatory pseudotumor of the lung with COX-2 inhibitor.
    Chan PW; Omar KZ; Ramanujam TM
    Pediatr Pulmonol; 2003 Aug; 36(2):167-9. PubMed ID: 12833497
    [No Abstract]   [Full Text] [Related]  

  • 19. Balancing risks and benefits in pain medicine: wither Vioxx.
    Gallagher RM
    Pain Med; 2004 Dec; 5(4):329-30. PubMed ID: 15563316
    [No Abstract]   [Full Text] [Related]  

  • 20. Vioxx doctors wooed by Merck are now its foes.
    Tesoriero HW
    Wall St J (East Ed); 2006 Mar; ():B1, B3. PubMed ID: 16578911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.